MELBRAN DRUGS, INC.
Share on:
| Name: | MELBRAN DRUGS, INC. |
| Jurisdiction: | New York |
| Legal type: | DOMESTIC BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 14 Oct 2004 (21 years ago) |
| Entity Number: | 3113726 |
| ZIP code: | 10032 |
| County: | New York |
| Place of Formation: | New York |
| Principal Address: | 605 W 168TH ST, NEW YORK, NY, United States, 10032 |
| Address: | 605 WEST 168TH STREET, NEW YORK, NY, United States, 10032 |
Contact Details
Phone +1 212-568-1300
Shares Details
Shares issued 200
Share Par Value 0
Type NO PAR VALUE
| Name | Role | Address |
|---|---|---|
| A KUMAR SURANENI | Chief Executive Officer | 605 W 168TH ST, NEW YORK, NY, United States, 10032 |
| Name | Role | Address |
|---|---|---|
| MELBRAN DRUGS, INC. | DOS Process Agent | 605 WEST 168TH STREET, NEW YORK, NY, United States, 10032 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2006-10-19 | 2008-11-03 | Address | 605 W 168TH ST, NEW YORK, NY, 10022, USA (Type of address: Chief Executive Officer) |
| 2006-10-19 | 2008-11-03 | Address | 605 W 168TH ST, NEW YORK, NY, 10022, USA (Type of address: Principal Executive Office) |
| 2004-10-14 | 2020-10-02 | Address | 605 WEST 168TH STREET, NEW YORK, NY, 10032, USA (Type of address: Service of Process) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 201002060842 | 2020-10-02 | BIENNIAL STATEMENT | 2020-10-01 |
| 181001008001 | 2018-10-01 | BIENNIAL STATEMENT | 2018-10-01 |
| 141208007583 | 2014-12-08 | BIENNIAL STATEMENT | 2014-10-01 |
| 121102002536 | 2012-11-02 | BIENNIAL STATEMENT | 2012-10-01 |
| 110301002841 | 2011-03-01 | BIENNIAL STATEMENT | 2010-10-01 |
This company hasn't received any reviews.
Date of last update: 29 Mar 2025
Sources: New York Secretary of State